Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...

Stopping GLP-1 therapy may disrupt glycemic control and reduce cardiovascular benefits without clear perioperative safety ...

“This drug isn't going to wipe out a whole statistic of women,” the supermodel and activist said of the popular weight-loss ...

Ashley Graham calls the rise of GLP-1 weight loss shots disheartening as she vows to continue advocating for plus-size women ...

Out-of-pocket costs, insurance coverage, side effects and a lack of long-term safety data can be barriers to medication for childhood obesity.

The majority of weight loss from GLP-1 medication is from fat loss, and not muscle loss, new evidence suggests.

The National Psoriasis Foundation has issued a detailed primer supporting GLP-1 receptor agonists as an adjunct therapy for psoriasis in patients with metabolic comorbidities. Evidence shows these ...

Ashley Graham is not happy with what the prevalence of GLP-1 drugs is doing to body positivity. The popular plus-size model is the cover star of Marie Claire’s latest Motherhood Issue, and she ...

While GLP-1 medications first gained visibility for diabetes care and later for weight loss, researchers are now evaluating ...

Ashley Graham is strutting into a conversation about weight loss drugs. The supermodel—who has been a longtime body positive ...